Click to search for your profile
Click to search for condition or expert
Click to open main menu
Acute Myeloblastic Leukemia with Maturation
Symptoms, Doctors, Treatments, Advances & More
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Condition 101
About Acute Myeloblastic Leukemia with Maturation
What are the alternative names for Acute Myeloblastic Leukemia with Maturation?
Acute myeloblastic leukemia type 2
Acute myeloblastic leukemia M2
AML M2
LAM M2
Top Global Doctors
For Acute Myeloblastic Leukemia with Maturation
Bookmark
Click to see options
HK
Elite
Hagop M. Kantarjian
Oncology
Hematology
Internal Medicine
Houston, TX
Bookmark
Click to see options
CD
Elite
Courtney D. Dinardo
Hematology
Oncology
Internal Medicine
Houston, TX
Bookmark
Click to see options
TK
Elite
Tapan M. Kadia
Internal Medicine
Houston, TX
Bookmark
Click to see options
RS
Elite
Richard M. Stone
Hematology
Oncology
Internal Medicine
Boston, MA
Bookmark
Click to see options
GB
Elite
Gautam Borthakur
Hematology
Oncology
Internal Medicine
Houston, TX
Bookmark
Click to see options
EE
Elite
Elihu H. Estey
Oncology
Hematology
Internal Medicine
Seattle, WA
Latest Advances
On Acute Myeloblastic Leukemia with Maturation
Condition:
Invasive Fungal Diseases (IFDs) in Patients Acute Myeloid Leukemia (AML)
Journal:
Medicine
Treatment Used:
Posaconazole Prophylaxis
Number of Patients:
247
Published —
May 20, 2021
This study compared the outcomes of invasive fungal diseases (IFDs) between patients with acute myeloid leukemia (AML) receiving posaconazole prophylaxis and those not receiving prophylaxis.
Condition:
Untreated Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy
Journal:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Treatment Used:
Venetoclax with Low-Dose Cytarabine
Number of Patients:
211
Published —
May 13, 2021
The aim of this study was to investigate the safety and effectiveness of venetoclax with low-dose cytarabine (LDAC) in patients with acute myeloid leukemia (AML) who are unable to tolerate intensive induction chemotherapy.
Clinical Trials
For Acute Myeloblastic Leukemia with Maturation
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
72
Start Date:
December 21, 2021
A Phase 1 Study of MLN7243 (TAK-243) for Either Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome/Chronic Myelomonocytic Leukemia Refractory to Hypomethylating Agents
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Behavioral
Participants:
20
Start Date:
December 1, 2021
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
